Keyvan Keyvanfar - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Keyvan Keyvanfar

Showing results (71-80 of 73) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 73 results.

Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2014

Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteersSawa Ito, Catherine M Bollard, Mattias Carlsten, et al.

Blood|January 8, 2025

Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragments covalently deposited on lymphoma cellsSivasubramanian Baskar, Haiyong Peng, Erika M Gaglione, et al.

Cell Metabolism|December 18, 2015

Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular TherapyMadhusudhanan Sukumar, Jie Liu, Gautam U Mehta, et al.

Pageof 8

Search research articles

Showing results (71-80 of 73) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 73 results.

Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2014

Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteersSawa Ito, Catherine M Bollard, Mattias Carlsten, et al.

Blood|January 8, 2025

Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragments covalently deposited on lymphoma cellsSivasubramanian Baskar, Haiyong Peng, Erika M Gaglione, et al.

Cell Metabolism|December 18, 2015

Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular TherapyMadhusudhanan Sukumar, Jie Liu, Gautam U Mehta, et al.

Pageof 8